文献速递青光眼眼底病与葡萄膜炎

近视性屈光不正与原发性开角型青光眼之间的关联:一项两样本孟德尔随机化研究

Association Between Myopic Refractive Error and Primary Open-Angle Glaucoma: A 2-Sample Mendelian Randomization Study.
PubMed 文献 · JAMA Ophthalmol · 2022-01-01

该研究利用GERA队列的观察性分析及两样本孟德尔随机化方法,评估近视性屈光不正与原发性开角型青光眼(POAG)风险的关联。观察性分析显示POAG患者近视和高近视比例更高;遗传相关分析显示POAG与平均球镜等效屈光不正(MSE)、近视及高近视存在遗传相关;孟德尔随机化提示遗传预测的MSE越偏向远视,POAG风险越低(OR 0.94每屈光度)。

要点

  • POAG患者近视比例为40.2%,对照组为34.1%,差异有统计学意义(P=1.31×10-11)。
  • POAG与MSE屈光不正的遗传相关系数rg为-0.24(SE 0.06,P=3.90×10-5)。
  • 遗传预测的MSE每增加1屈光度(更远视),POAG风险OR为0.94(95%CI 0.89-0.99,P=0.01)。

核心结论

  • 研究显示近视性屈光不正与POAG风险存在共享遗传基础及关联,可能支持基于屈光信息的POAG风险分层和筛查策略。

研究设计与样本

  • 观察性分析纳入GERA队列中54755名非西班牙裔白人个体,评估MSE屈光不正或近视与POAG风险的关联。
  • 全基因组遗传相关分析使用GERA的MSE屈光不正、近视和POAG的GWAS数据。
  • 两样本孟德尔随机化中,MSE屈光不正的遗传变异来自102117名英国生物银行参与者的GWAS汇总统计。
  • POAG的GWAS汇总统计来自既往GWAS,包括3836例POAG病例和48065名对照。
  • 数据分析于2020年7月至2021年10月进行。

主要发现

  • 在4047例POAG患者中,平均(SD)年龄为73.64(9.20)岁;50708名对照的平均(SD)年龄为65.38(12.24)岁。
  • POAG患者相比对照有更低的屈光MSE,且更可能患有近视或高近视(近视:40.2% vs 34.1%,P=1.31×10-11;高近视:8.5% vs 6.8%,P=0.004)。
  • 遗传相关分析显示POAG与MSE屈光不正(rg=-0.24;SE=0.06;P=3.90×10-5)、近视(rg=0.21;SE=0.07;P=0.004)和高近视(rg=0.23;SE=0.09;P=0.01)存在遗传相关。
  • 遗传评估的屈光MSE与POAG风险呈负相关(逆方差加权模型:每屈光度更远视的MSE,OR=0.94;95%CI 0.89-0.99;P=0.01)。

临床怎么用

  • 原文结论指出这些发现可能支持基于屈光信息的POAG风险分层和筛查策略。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Refractive error (RE) is the most common form of visual impairment, and myopic RE is associated with an increased risk of primary open-angle glaucoma (POAG). Whether this association represents a causal role of RE in the etiology of POAG remains unknown. OBJECTIVE: To evaluate shared genetic influences and investigate the association of myopic RE with the risk for POAG. DESIGN, SETTING, AND PARTICIPANTS: Observational analyses were used to evaluate the association between mean spherical equivalent (MSE) RE (continuous trait) or myopia (binary trait) and POAG risk in individuals from the Genetic Epidemiology Research on Adult Health and Aging (GERA) cohort. To quantify genetic overlap, genome-wide genetic correlation analyses were performed using genome-wide association studies (GWAS) of MSE RE or myopia and POAG from GERA. Potential causal effects were assessed between MSE RE and POAG using 2-sample Mendelian randomization. Genetic variants associated with MSE RE were derived using GWAS summary statistics from a GWAS of RE conducted in 102 117 UK Biobank participants. For POAG, we used GWAS summary statistics from our previous GWAS (3836 POAG cases and 48 065 controls from GERA). Data analyses occurred between July 2020 and October 2021. MAIN OUTCOMES AND MEASURE: Our main outcome was POAG risk as odds ratio (OR) caused by per-unit difference in MSE RE (in diopters). RESULTS: Our observational analyses included data for 54 755 non-Hispanic White individuals (31 926 [58%] females and 22 829 [42%] males). Among 4047 individuals with POAG, mean (SD) age was 73.64 (9.20) years; mean (SD) age of the 50 708 controls was 65.38 (12.24) years. Individuals with POAG had a lower refractive MSE and were more likely to have myopia or high myopia compared with the control participants (40.2% vs 34.1%, P = 1.31 × 10-11 for myopia; 8.5% vs 6.8%, P = .004 for high myopia). Our genetic correlation analyses demonstrated that POAG was genetically correlated with MSE RE (rg, -0.24; SE, 0.06; P = 3.90 × 10-5), myopia (rg, 0.21; SE, 0.07; P = .004), and high myopia (rg, 0.23; SE, 0.09; P = .01). Genetically assessed refractive MSE was negatively associated with POAG risk (inverse-variance weighted model: OR per diopter more hyperopic MSE = 0.94; 95% CI, 0.89-0.99; P = .01). CONCLUSIONS AND RELEVANCE: These findings demonstrate a shared genetic basis and an association between myopic RE and POAG risk. This may support population POAG risk stratification and screening strategies, based on RE information.

来源:JAMA Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Choquet H, Khawaja AP, Jiang C, et al. Association Between Myopic Refractive Error and Primary Open-Angle Glaucoma: A 2-Sample Mendelian Randomization Study. JAMA Ophthalmol. 2022. PMID: 35900730. doi:10.1001/jamaophthalmol.2022.2762

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。